Publications by authors named "Marius MacKenzie"

Claim this Profile
B
Bortezomib maintenance after R-CHOP, cytarabine and autologous stem cell transplantation in newly diagnosed patients with mantle cell lymphoma, results of a randomised phase II HOVON trial.
Jeanette K Doorduijn, Josee M Zijlstra, Pieternella J Lugtenburg, Marie Josee Kersten, Lara H Böhmer, Marius A MacKenzie

Br J Haematol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exome sequencing in routine diagnostics: a generic test for 254 patients with primary immunodeficiencies.
Peer Arts, Annet Simons, Mofareh S AlZahrani, Elanur Yilmaz, Eman AlIdrissi, Marius A MacKenzie

Genome Med· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of secondary central nervous system lymphoma with intrathecal rituximab, high-dose methotrexate, and R-DHAP followed by autologous stem cell transplantation: results of the HOVON 80 phase 2 study.
Jeanette K Doorduijn, Gustaaf W van Imhoff, Bronno van der Holt, Harry C Schouten, Martijn R Schaafsma, Marius A MacKenzie

Hematol Oncol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytomorphology review of 100 newly diagnosed lower-risk MDS patients in the European LeukemiaNet MDS (EUMDS) registry reveals a high inter-observer concordance.
Louise de Swart, Alex Smith, Marius MacKenzie, Argiris Symeonidis, Judith Neukirchen

Ann Hematol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second international round robin for the quantification of serum non-transferrin-bound iron and labile plasma iron in patients with iron-overload disorders.
Louise de Swart, Jan C M Hendriks, Lisa N van der Vorm, Z Ioav Cabantchik, Patricia J Evans, Marius A MacKenzie

Haematologica· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the revised international prognostic scoring system (IPSS-R) in patients with lower-risk myelodysplastic syndromes: a report from the prospective European LeukaemiaNet MDS (EUMDS) registry.
Louise de Swart, Alex Smith, Thomas W Johnston, Detlef Haase, Jackie Droste, Marius MacKenzie

Br J Haematol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A dominant-negative GFI1B mutation in the gray platelet syndrome.
Davide Monteferrario, Nikhita A Bolar, Anna E Marneth, Konnie M Hebeda, Saskia M Bergevoet, Marius A MacKenzie

N Engl J Med· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent advances in the understanding of iron overload in sideroblastic myelodysplastic syndrome.
Maria L H Cuijpers, Reinier A P Raymakers, Marius A Mackenzie, Theo J M de Witte, Dorine W Swinkels

Br J Haematol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical images: Castleman disease and paraneoplastic pemphigus.
Else N Kop, Marius A MacKenzie

CMAJ· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose Ara-C and beam with autograft rescue in R-CHOP responsive mantle cell lymphoma patients.
Mars B van 't Veer, Daphne de Jong, Marius MacKenzie, Hanneke C Kluin-Nelemans, Marinus H J van Oers

Br J Haematol· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensified 12-week CHOP (I-CHOP) plus G-CSF compared with standard 24-week CHOP (CHOP-21) for patients with intermediate-risk aggressive non-Hodgkin lymphoma: a phase 3 trial of the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON).
Leo F Verdonck, Annelise Notenboom, Daphne D de Jong, Marius A MacKenzie, Gregor E G Verhoef

Blood· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic significance of the intra-follicular tumor cell proliferative rate in follicular lymphoma.
Ad Koster, Hedwig A Tromp, John M M Raemaekers, George F Borm, Konnie Hebeda, Marius A Mackenzie

Haematologica· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of three courses of intensified CHOP prior to high-dose sequential therapy followed by autologous stem-cell transplantation as first-line treatment in poor-risk, aggressive non-hodgkin's lymphoma: comparative analysis of Dutch-Belgian Hemato-Oncology Cooperative Group Studies 27 and 40.
Gustaaf W van Imhoff, Bronno van der Holt, Marius A Mackenzie, Mars B Van't Veer, Pierre W Wijermans

J Clin Oncol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased vascularization predicts favorable outcome in follicular lymphoma.
Ad Koster, Joannes H J M van Krieken, Marius A Mackenzie, Margit Schraders, George F Borm

Clin Cancer Res· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis